Hyperekplexia phenotype due to compound heterozygosity for GLRA1 gene mutations
Authors:
- 1 October 1999
- journal article
- case report
- Published by Wiley in Annals of Neurology
- Vol. 46 (4) , 634-638
Abstract
Hyperekplexia (MIM 149400), or startle disease, is a neurological disorder characterized by generalized stiffness during the neonatal period, excessive startle reflexes, and generalized stiffness related to the startle response. Linkage analysis mapped a major gene for this disorder to chromosome 5q33‐35. Subsequently, mutations in the GLRA1 gene, encoding the α1 subunit of the glycine receptor, were found in hyperekplexia families with an autosomal dominant or recessive inheritance pattern. In the present study, we describe the genetic analysis of the GLRA1 gene of a family consisting of 2 children with hyperekplexia, 2 nonaffected children, and their healthy nonconsanguineous parents. Although the pedigree suggested the presence of a recessive mutation, haplotype construction showed that the 2 affected children shared the same haplotype combination in which the maternal haplotype differed from the paternal haplotype, suggesting the presence of compound heterozygosity. Mutation analysis revealed different missense mutations on the two haplotypes, changing an arginine to a histidine at amino acid positions 252 and 392, respectively. It is interesting that the hyperekplexia phenotype was only seen in individuals compound heterozygous for the two mutations, whereas family members carrying either one of the two mutations had no clinical signs.Keywords
This publication has 19 references indexed in Scilit:
- NovelGLRA1Missense Mutation (P250T) in Dominant Hyperekplexia Defines an Intracellular Determinant of Glycine Receptor Channel GatingJournal of Neuroscience, 1999
- Analysis of GLRA1 in hereditary and sporadic hyperekplexia: a novel mutation in a family cosegregating for hyperekplexia and spastic paraparesis.Journal of Medical Genetics, 1996
- Mutational analysis of familial and sporadic hyperekplexiaAnnals of Neurology, 1995
- Molecular Genetic Reevaluation of the Dutch Hyperekplexia FamilyArchives of Neurology, 1995
- Mutation of an arginine residue in the human glycine receptor transforms β-alanine and taurine from agonists into competitive antagonistsNeuron, 1995
- Evidence for recessive as well as dominant forms of startle disease (hyperekplexia) caused by mutations in the α1 subunit of the inhibitory glycine receptorHuman Molecular Genetics, 1994
- An additional family with Startle disease and a G1192A mutation at the α1 subunit of the inhibitory glycine receptor geneHuman Molecular Genetics, 1994
- Mutations in the α1 subunit of the inhibitory glycine receptor cause the dominant neurologic disorder, hyperekplexiaNature Genetics, 1993
- Startle disease, or hyperekplexia: Response to clonazepam and assignment of the gene (STHE) to chromosome 5q by linkage analysisAnnals of Neurology, 1992
- HyperexplexiaJournal of the Neurological Sciences, 1966